BioPorto, status of Trauma Patent at USPTO (II)

By On 15. July 2012 · Leave a Comment · In BioPorto

Last week I gave myself a fright, when browsing the Trauma Patent application by BioPorto. The awful words “final rejection” were hanging in the air, until Corporate Lawyer Gry eased my troubled mind…

In her mail she indicated that BioPorto was prepairing a response to USPTO…

Well , she was very much to the point on july 10th the response – with proposed amendments  was filed. These are the new claims:

Claims Trauma Patent july 2012

The amendments : Basically BioPorto mentions that obviousness argument and the double patenting is irrelevant – because BioPorto filed their application first and because the Trauma patent is excluding kidney injury.

Remarks on the amended claims Trauama Patent 2012

About Stengaard

BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂

Related posts:

  1. BioPorto, status of Trauma Patent at USPTO I said to myself  “I wonder what the present status...
  2. APC-PCI patent – status at EPO/USPTO Some have described BioPorto as a “one trick pony” –...
  3. NEW PATENT: Methods For Rapid Assessment of Severity of a Trauma On the 28’th of December 2011, EPO issued the patent...
  4. Bioporto, status på Traumepatent USPTO Bioporto, hvad er mon egentlig status på Traumepatent i USPTO...
  5. Applicant Arguments on the USPTO non-final rejection of the “NGAL exclusion patent” application. (Page 1) ...
 

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.